ISA $millionaire

What an amazing twelve months it has been.  And what an amazing month March 2020 was.

March 2020 saw global equities down 25% on peak, just a few weeks earlier.  VWRL dropped to £57, a level it hadn’t been at since 2016.  That left my ISAs feeling very down in the dumps.

Since March 2020, VWRL has climbed to £83, almost 14% above its previous cycle’s peak. My ISAs are looking very plump indeed.

Continue reading “ISA $millionaire”

2021 Q1 – the camel’s head appears

My portfolio went up over 3% in January. But then came down again.

The same happened in February. I concluded the month feeling somewhat ‘humped’ by the market, twice. Hence my post about two-humped camels (Bactrian camels, as it turns out – ahem).

So as the end of March approached, with my portfolio again up about 3%, I kept expecting a correction. But as at the time of writing, no correction has yet occurred.

Meanwhile, the news in March seemed full of vaccines. The UK has now vaccinated over half its adults. The US, about a quarter. The EU, is bringing up the rear, with about half of that. The headlines were full of vaccine wars, blood clots, second doses, you name it.

The other key story in London was the horrible news about 30-something Sarah Everard who was abducted and killed on one of the popular green spaces, Clapham Common, by a stranger – a policeman no less. The story hit the headlines because of how rare this sort of stuff is these days. There are only around 20 women killed in the UK every year by strangers, which suggests 5 or fewer per year in London.

Continue reading “2021 Q1 – the camel’s head appears”

Jan 2021 review – spring cleaning underway

The end of 2021’s first month.

January 2021 was quite an eventful month. Vaccine wars (amidst which, the UK has managed over 9m vaccines, thank goodness). Gameshop / WallStreetBets/ DeepFuckingValue memes. Trump’s coup over, Biden’s presidency now in place. Plenty going on.

Lockdown continues relentlessly in the UK. My area of London is proving to be reasonably compliant, to boot. Local covid-19 cases have halved since the early January peak, but remain far too high for comfort. Thankfully a large number of ‘oldies’ have been vaccinated, I know from personal experience, so with luck in a few weeks we will see that impact feeding through in the hospital statistics.

The markets ramped quite impressively in January, until they didn’t. The month end numbers suggest there isn’t much to see here – the month end hiding some quite vivid action.

In the meantime, I was very busy – trying to (partially, at least) replace my portfolio with one (ish) ETF. I’ll report on my progress below.

Continue reading “Jan 2021 review – spring cleaning underway”